Evaluating the impact of treatments and clinical factors on thyroid cancer outcomes
Retrospective and Prospective Evaluation of the Impact of Innovative and Conventional Treatments and of Clinical Variables on the Outcome of Thyroid Cancer
This study looks at how different treatments and health factors affect the outcomes for people with thyroid cancer to help identify which patients might need less aggressive treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Sex | All |
| Sponsor | Istituto Auxologico Italiano Academic / other |
| Locations | 1 site (Milan) |
| Trial ID | NCT05752604 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients diagnosed with thyroid cancer to assess how various clinical and histopathological factors influence their prognosis. By analyzing anamnestic data and treatment interventions, the study aims to differentiate between aggressive and indolent tumor behaviors, potentially reducing unnecessary treatments. The outcomes will include morbidity, mortality, and the effectiveness of therapeutic choices, along with any adverse events associated with treatments.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with thyroid cancer who can provide informed consent.
Not a fit: Patients who are unable to sign informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more personalized treatment approaches for thyroid cancer patients, improving outcomes and reducing overtreatment.
How similar studies have performed: While this approach is observational and builds on existing knowledge, similar studies have shown promise in improving treatment strategies for cancer patients.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- thyroid cancer diagnosis Exclusion Criteria: * patients unable to sign informed consent
Where this trial is running
Milan
- Istituto Auxologico Italiano, IRCCS — Milan, Italy (Recruiting)
Study contacts
- Study coordinator: Laura Fugazzola, MD
- Email: l.fugazzola@auxologico.it
- Phone: +390261911
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.